Pratibha Binder

Title(s)Associate Physician, Ob/Gyn & Reproductive sciences
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Overview 
    Collapse Websites

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Disparities in time to start of definitive radiation treatment for patients with locally advanced cervical cancer. Int J Gynecol Cancer. 2022 May 03; 32(5):613-618. Kotha NV, Williamson CW, Mell LK, Murphy JD, Martinez E, Binder PS, Mayadev JS. PMID: 35428688.
      View in: PubMed   Mentions:
    2. The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer. BMC Cancer. 2022 Mar 12; 22(1):263. Binder PS, Hashim YM, Cripe J, Buchanan T, Zamorano A, Vangveravong S, Mutch DG, Hawkins WG, Powell MA, Spitzer D. PMID: 35279106; PMCID: PMC8918278.
      View in: PubMed   Mentions:
    3. Pregnancy-associated large pelvic desmoid tumor: A case report of fetal-protective strategies and fertility preservation. Gynecol Oncol Rep. 2022 Feb; 39:100901. Marsh-Armstrong B, Veerapong J, Taddonio M, Boles S, Sicklick JK, Binder P. PMID: 35531359; PMCID: PMC9068953.
      View in: PubMed   Mentions:
    4. Cochrane Review Summaries-July 2021. Obstet Gynecol. 2021 Dec 01; 138(6):947. Binder P, Parker W. PMID: 34794163.
      View in: PubMed   Mentions:
    5. Practice patterns and survival in FIGO 2009 stage 3B endometrial cancer. Gynecol Oncol. 2021 11; 163(2):299-304. Jou J, Charo L, Hom-Tedla M, Coakley K, Binder P, Saenz C, Eskander RN, McHale M, Plaxe S. PMID: 34561099.
      View in: PubMed   Mentions:    Fields:    
    6. PTEN Loss and ARID1A Mutation in an HPV-positive Metastatic Adenocarcinoma Diagnosed Almost 18 yr After an Intact Cone Excision for Endocervical Adenocarcinoma In Situ. Int J Gynecol Pathol. 2022 May 01; 41(3):307-312. Aisagbonhi O, Zare SY, Hasteh F, Binder P, Roma AA, Fadare O. PMID: 34282106.
      View in: PubMed   Mentions:    Fields:    
    7. Placenta Accreta Spectrum Treatment With Intraoperative Multivessel Embolization: the PASTIME protocol. Am J Obstet Gynecol. 2021 10; 225(4):442.e1-442.e10. Melber DJ, Berman ZT, Jacobs MB, Picel AC, Conturie CL, Zhang-Rutledge K, Binder PS, Eskander RN, Roberts AC, McHale MT, Ramos GA, Ballas J, Kelly TF. PMID: 34245679.
      View in: PubMed   Mentions:    Fields:    
    8. Trends and geographic variation in women's representation as principal investigators (PI) in phase 3 gynecologic oncology clinical trials. Gynecol Oncol. 2021 08; 162(2):389-393. Jou J, Brodsky A, Charo L, Binder P, Saenz C, Eskander RN, McHale M, Plaxe S. PMID: 34099315.
      View in: PubMed   Mentions:    Fields:    
    9. Assessment of malnutrition by unintentional weight loss and its implications on oncologic outcomes in patient with locally advanced cervical cancer receiving primary chemoradiation. Gynecol Oncol. 2021 03; 160(3):721-728. Jou J, Coulter E, Roberts T, Binder P, Saenz C, McHale M, Plaxe S, Mayadev J, Eskander RN. PMID: 33342621.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. HIPEC after neoadjuvant chemotherapy and interval debulking is associated with development of platinum-refractory or -resistant disease. Gynecol Oncol. 2021 04; 161(1):25-33. Jou J, Zimmer Z, Charo L, Yau C, Saenz C, Eskander R, McHale M, Veerapong J, Plaxe S, Binder P. PMID: 33293046.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Charting a professional course for academic gynecologic oncology mentors. Gynecol Oncol. 2021 01; 160(1):265-270. Jou J, Binder P, Saenz C, Eskander R, McHale M, Plaxe S. PMID: 33131903.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Current status of hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer in the United States. Gynecol Oncol. 2020 12; 159(3):681-686. Charo LM, Jou J, Binder P, Hohmann SF, Saenz C, McHale M, Eskander RN, Plaxe S. PMID: 32977989.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    13. Phase 1 Trial of Concurrent Gemcitabine and Cisplatin with Image Guided Intensity Modulated Radiation Therapy for Locoregionally Advanced Cervical Carcinoma. Int J Radiat Oncol Biol Phys. 2020 08 01; 107(5):964-973. Mell LK, Xu R, Yashar CM, McHale MT, Einck JP, Mayadev J, Lee E, Binder P, Rash D, Eskander R, Heide ES, Plaxe SC, Mundt AJ, Saenz CC. PMID: 32334034.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    14. Rapid dissemination of practice-changing information: A longitudinal analysis of real-world rates of minimally invasive radical hysterectomy before and after presentation of the LACC trial. Gynecol Oncol. 2020 05; 157(2):494-499. Charo LM, Vaida F, Eskander RN, Binder P, Saenz C, McHale M, Plaxe S. PMID: 32081462.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. Benefit of combination chemotherapy and radiation stratified by grade of stage IIIC endometrial cancer. Gynecol Oncol. 2017 11; 147(2):309-314. Binder PS, Kuroki LM, Zhao P, Cusworth S, Divine LM, Hagemann AR, McCourt CK, Thaker PH, Powell MA, Mutch DG, Massad LS. PMID: 28916118.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    16. The Targeted SMAC Mimetic SW IV-134 is a strong enhancer of standard chemotherapy in pancreatic cancer. J Exp Clin Cancer Res. 2017 01 17; 36(1):14. Hashim YM, Vangveravong S, Sankpal NV, Binder PS, Liu J, Goedegebuure SP, Mach RH, Spitzer D, Hawkins WG. PMID: 28095907; PMCID: PMC5240213.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    17. Reply. Am J Obstet Gynecol. 2017 02; 216(2):192-193. Binder PS, Massad LS, Mutch DG, Powell MA, Thaker PH, McCourt CK, Peipert JF, Kallogjeri D, Brooks RA. PMID: 27640937.
      View in: PubMed   Mentions:    Fields:    
    18. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients. Am J Obstet Gynecol. 2016 Dec; 215(6):766.e1-766.e9. Binder PS, Peipert JF, Kallogjeri D, Brooks RA, Massad LS, Mutch DG, Powell MA, Thaker PH, McCourt CK. PMID: 27457116; PMCID: PMC5124522.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    19. Mesothelin's minimal MUC16 binding moiety converts TR3 into a potent cancer therapeutic via hierarchical binding events at the plasma membrane. Oncotarget. 2016 May 24; 7(21):31534-49. Su Y, Tatzel K, Wang X, Belt B, Binder P, Kuroki L, Powell MA, Mutch DG, Hawkins WG, Spitzer D. PMID: 27120790; PMCID: PMC5058776.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    20. Self-reported human papillomavirus vaccination does not have an impact on the risk for high-grade cervical intraepithelial neoplasia among women referred for colposcopy. Am J Obstet Gynecol. 2016 07; 215(1):123-6. Kuroki LM, Binder PS, Powell MA, Massad LS, Gao F. PMID: 26944187; PMCID: PMC5067105.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    21. The future role of molecular staging in gynecologic cancer. Int J Gynaecol Obstet. 2015 Oct; 131 Suppl 2:S127-31. Binder PS, Prat J, Mutch DG. PMID: 26433669.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. Molecular staging of gynecological cancer: What is the future? Best Pract Res Clin Obstet Gynaecol. 2015 Aug; 29(6):776-89. Binder PS, Prat J, Mutch DG. PMID: 25934522; PMCID: PMC4532616.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    23. Update on prognostic markers for endometrial cancer. Womens Health (Lond). 2014 May; 10(3):277-88. Binder PS, Mutch DG. PMID: 24956294.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    Pratibha's Networks
    Concepts (152)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (33)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version v3.1.0-871-g21b54b14 on PROFILES-PWEB01.

    Copyright © The Regents of the University of California